Investment Committee Process: How Private Capital Decisions Are Made

Private capital investment decisions are rarely made by one individual. Even when an opportunity is introduced by a senior partner or experienced deal professional, the proposed transaction normally passes through a structured review process before capital can be committed.

The investment committee is a central part of that process. Its role is to test whether an opportunity fits the investment mandate, whether the underlying evidence is sufficiently reliable and whether the proposed return potential justifies the identified risks.

An investment committee does not remove uncertainty from a transaction. Instead, it creates an accountable decision framework in which assumptions can be challenged, conflicts can be addressed and approval conditions can be clearly documented.

What is an investment committee?

An investment committee is a formal decision-making body responsible for reviewing proposed investments and determining whether they should proceed. Its authority, composition and operating procedures differ between private equity firms, family offices, investment funds and other private capital organisations.

Depending on the organisation, the committee may include senior investment professionals, managing partners, risk specialists, operating executives, finance representatives or independent advisers. Legal, tax, technical and sector experts may also contribute to the review without holding a formal vote.

The committee’s responsibilities may include:

• confirming that the opportunity fits the approved investment mandate;
• reviewing the quality and completeness of due diligence;
• challenging financial assumptions and valuation;
• examining commercial, legal, operational and financial risks;
• assessing the proposed transaction structure and governance rights;
• considering the effect on the existing portfolio;
• identifying actual or potential conflicts of interest;
• approving, declining, postponing or conditionally approving the investment.

The committee should provide independent challenge rather than simply confirm the recommendation of the deal team.

Why private capital firms use investment committees

Private investments often involve limited liquidity, incomplete information and long holding periods. These characteristics make disciplined decision-making especially important.

A structured committee process helps reduce several common risks.

Confirmation bias

The professionals who source and develop an opportunity may become increasingly confident in the transaction as they invest time in it. A separate committee can challenge whether the evidence genuinely supports that confidence.

Incomplete risk identification

Different committee members may identify issues that the original deal team has not fully considered. These can include portfolio concentration, governance limitations, funding risk, legal exposure or operational dependencies.

Inconsistent decision standards

A formal review process allows opportunities to be assessed against a consistent set of principles rather than the personal preferences of individual investment professionals.

Weak accountability

Documented committee decisions create a record of the information considered, the conditions imposed and the reasoning behind the outcome. This can support later monitoring and governance.

The investment committee process begins before the meeting

The committee meeting is only one stage of the decision process. Substantial work normally takes place before the opportunity is formally presented.

The investment team must develop an evidence-based case that explains why the transaction should proceed and how the principal risks will be managed. This work often includes preliminary screening, due diligence, financial modelling, valuation analysis, legal review and negotiation of key transaction terms.

An opportunity that has not been sufficiently investigated should not be advanced merely to obtain a quick decision. The committee is most effective when it receives complete, clearly organised and decision-relevant information.

Stage one: preliminary mandate review

Before a full investment memorandum is prepared, the opportunity is usually tested against the investor’s mandate. This prevents significant resources from being committed to transactions that cannot ultimately be approved.

The mandate review may examine:

• sector and industry eligibility;
• geographic exposure;
• company maturity and operating history;
• minimum or maximum capital requirements;
• permitted instruments and transaction types;
• expected ownership position;
• investment horizon;
• portfolio concentration limits;
• risk, governance and liquidity requirements.

An opportunity may be commercially attractive but unsuitable for a particular investor. Mandate fit is therefore a threshold question rather than a final judgment on the quality of the business.

Sharemont’s general assessment principles are described in the Investment Approach.

Stage two: preparing the investment memorandum

The investment memorandum is the principal document used to present the proposed transaction to the committee. It should convert a large volume of research and diligence into a clear decision framework.

A strong memorandum does not function as a promotional presentation. It should explain both the case for investment and the reasons the transaction could fail.

Executive summary

The executive summary should identify the company, transaction, required capital, proposed structure and principal reasons for the recommendation. It should also state the most material risks and unresolved matters.

Investment thesis

The investment thesis explains how the opportunity is expected to create value. It may be based on market growth, operational improvement, pricing development, expansion into new channels, strategic acquisitions, improved governance or another identifiable value driver.

The thesis should be specific enough to monitor after investment. General statements such as “the market is large” or “the company has strong potential” do not provide a measurable basis for approval.

Commercial assessment

The memorandum should explain the company’s products or services, customer base, competitive position, distribution model and market conditions. Material customer concentration, supplier dependence and regulatory exposure should be clearly identified.

Management assessment

The committee needs to understand whether the leadership team can execute the strategy. The memorandum may discuss management experience, organisational gaps, succession risk, reporting quality and the proposed incentive structure.

Financial analysis

The financial section should cover historical performance, current trading, cash flow, debt, working capital and forecast assumptions. It should also explain any adjustments made to reported earnings or management projections.

Transaction structure

The proposed structure should describe the security or instrument, valuation, ownership, governance rights, funding schedule, conditions precedent and potential dilution.

Risk analysis

The memorandum should distinguish between risks that can be mitigated, risks that can only be monitored and risks that may make the transaction unsuitable.

Recommendation

The final recommendation should state precisely what approval is being requested. This may include authority to sign definitive documents, continue negotiations within specified parameters or complete additional diligence.

A credible investment memorandum should make it possible to understand not only why the opportunity may succeed, but also what would invalidate the investment case.

Stage three: reviewing due diligence findings

Before approval, the committee should understand what has been verified and what remains dependent on management representations or future events.

Due diligence may cover several areas.

Commercial diligence

This may include customer interviews, competitor research, market sizing, pricing analysis, product positioning and review of the sales pipeline.

Financial diligence

Financial diligence may examine revenue recognition, recurring income, quality of earnings, working capital, debt, cash balances and historical forecast accuracy.

Legal diligence

Legal review may cover ownership, material contracts, intellectual property, litigation, employment matters, regulatory requirements and existing investor rights.

Operational and technical diligence

Depending on the company, the review may examine production capacity, information systems, cybersecurity, product quality, supply chains, insurance and business continuity.

The committee should be informed when diligence findings are incomplete, disputed or dependent on post-closing action. Unresolved issues should not be hidden in technical appendices.

Stage four: financial modelling and scenario analysis

Financial modelling helps the committee understand how the proposed investment may perform under different operating and market conditions.

The model should connect operational assumptions to revenue, costs, cash generation, financing requirements and investor outcomes. It should not rely only on management’s central forecast.

Base case

The base case represents the investment team’s assessment of a reasonably achievable outcome. It should reflect evidence rather than simply reproduce management’s expectations.

Upside case

The upside case may consider stronger sales, faster market expansion, higher margins or successful strategic initiatives. The assumptions should remain plausible rather than aspirational.

Downside case

The downside case may test slower growth, delayed customer acquisition, lower pricing, increased costs or additional working-capital requirements.

Severe downside case

A severe downside analysis considers what could happen if several adverse events occur together. This can reveal whether the company may require emergency funding, breach debt obligations or lose strategic flexibility.

The committee should understand which assumptions have the greatest effect on the outcome and whether the proposed transaction remains acceptable when those assumptions are weakened.

Stage five: valuation review

Valuation affects both potential return and downside protection. The committee therefore considers whether the proposed price is supported by the company’s current condition, future prospects and transaction risk.

Possible valuation methods include:

• comparable-company analysis;
• precedent transaction analysis;
• discounted cash-flow analysis;
• asset-based valuation;
• revenue or earnings multiples;
• scenario-based valuation ranges.

The committee may challenge whether the selected comparables are genuinely relevant, whether the forecast period is credible and whether the valuation adequately reflects illiquidity and execution risk.

Approval may depend on renegotiating the valuation or changing another part of the transaction structure.

Stage six: transaction structure and investor protections

Two investments with the same headline valuation can have materially different risk profiles because of their legal and economic structure.

The committee may review:

• the type and seniority of the investment instrument;
• ownership and voting rights;
• board representation or observer rights;
• information and inspection rights;
• reserved matters requiring investor approval;
• dividend, interest or distribution provisions;
• anti-dilution and pre-emption rights;
• future financing requirements;
• transfer, exit and liquidity provisions;
• conditions attached to staged funding.

These provisions cannot eliminate business risk, but they can define how material decisions are made and how information is shared after investment.

Stage seven: portfolio-level review

An investment may appear attractive when considered alone but create unacceptable exposure when combined with the existing portfolio.

The committee may therefore assess:

• sector concentration;
• geographic concentration;
• common customer or supplier dependencies;
• exposure to the same economic or regulatory risk;
• future capital reserves;
• liquidity requirements;
• the capacity of the investment team to monitor the company;
• the expected timing of other portfolio commitments.

A transaction may be declined because the portfolio already has sufficient exposure to a particular risk, even when the company itself is considered investable.

Stage eight: conflicts of interest

Conflicts of interest can affect the independence of an investment decision. They should therefore be identified and addressed before approval.

Potential conflicts may arise when:

• a committee member has a personal or commercial relationship with the company;
• an affiliate is involved in the transaction;
• different investment vehicles may compete for the same opportunity;
• an existing portfolio company has an interest in the proposed transaction;
• fees or incentives could influence the recommendation;
• confidential information from another relationship affects the analysis.

Appropriate measures may include disclosure, recusal from discussion or voting, independent review or additional approval requirements.

What happens during the investment committee meeting?

The exact meeting format varies, but a structured discussion commonly includes several stages.

Presentation of the opportunity

The deal team summarises the company, transaction, investment thesis, diligence findings, valuation and proposed terms.

Clarification of factual matters

Committee members may ask for clarification of financial data, market evidence, legal matters or assumptions in the investment model.

Challenge of the investment thesis

The committee tests whether the proposed value drivers are supported by evidence and whether management has the resources to execute the plan.

Downside discussion

The discussion should examine what could cause loss, delay or further funding requirements. This stage is especially important when forecasts depend on a small number of assumptions.

Review of proposed protections

The committee considers whether governance rights, conditions and transaction terms are proportionate to the identified risks.

Decision and conditions

After discussion, the committee records its decision and any conditions that must be satisfied before the transaction can proceed.

Possible investment committee decisions

An investment committee is not limited to a simple approval or rejection. Several outcomes are possible.

Approved

The committee authorises the investment on the terms presented, subject to completion of the required documentation and closing process.

Conditionally approved

The transaction may proceed only after specified conditions are satisfied. These may include revised legal terms, additional diligence, management changes or confirmation of financing arrangements.

Approved within parameters

The team may receive authority to continue negotiations within defined valuation, ownership or governance limits. A material change may require the transaction to return to the committee.

Deferred

The committee may postpone the decision until further information becomes available or an unresolved issue is addressed.

Declined

The committee may determine that the transaction does not meet the required investment standard or does not fit the current portfolio.

Investment committee decision framework

Review stage	Principal question	Evidence considered	Possible outcome
Mandate review	Does the opportunity fit the permitted strategy?	Sector, geography, size, instrument and holding period	Proceed, redirect or decline
Investment memorandum	Is the investment thesis clear and measurable?	Commercial analysis, financial data and strategic plan	Request revision or advance to committee
Due diligence	Have material claims and risks been verified?	Financial, commercial, legal and operational findings	Proceed, impose conditions or defer
Financial model	How does the investment perform under different scenarios?	Base, upside, downside and severe downside cases	Revise assumptions, restructure or proceed
Valuation	Does the proposed price reflect risk and return potential?	Comparable analysis, forecasts and valuation ranges	Approve, renegotiate or decline
Structure	Are governance and economic rights appropriate?	Term sheet, ownership, investor protections and funding conditions	Approve subject to revised terms
Portfolio fit	What exposure does the transaction add?	Concentration, reserves, liquidity and monitoring capacity	Approve, reduce commitment or decline
Final decision	Should capital be committed?	Complete committee record and recommendation	Approve, conditionally approve, defer or decline

Common reasons a decision may be deferred

Deferral does not necessarily mean that the investment has been rejected. It often indicates that the committee cannot make a sufficiently informed decision based on the current evidence.

Common reasons include:

• missing or inconsistent financial information;
• unfinished legal or commercial diligence;
• unresolved ownership or intellectual-property questions;
• uncertain funding requirements;
• unverified customer or revenue assumptions;
• material changes in the transaction terms;
• insufficient downside analysis;
• the need for specialist technical advice;
• unresolved conflicts of interest.

Common reasons an investment may be declined

A committee may decline a transaction even after significant diligence has been completed. Common reasons include:

• the expected return does not compensate for the risk;
• the valuation remains unsupported;
• the management team cannot demonstrate sufficient execution capacity;
• the investment requires more capital than the portfolio can responsibly reserve;
• the proposed governance rights are inadequate;
• material diligence concerns cannot be resolved;
• the downside could lead to unacceptable capital impairment;
• the transaction creates excessive portfolio concentration;
• the opportunity no longer fits the investment mandate.

A decline does not always mean that the underlying business is unsuitable for every investor. Different firms may have different mandates, risk tolerances and portfolio constraints.

What happens after committee approval?

Approval is usually followed by completion of the transaction rather than an immediate transfer of capital.

Post-approval work may include:

• negotiating and signing definitive documents;
• satisfying conditions precedent;
• confirming regulatory or third-party approvals;
• completing final verification procedures;
• establishing governance and reporting arrangements;
• confirming the funding schedule;
• preparing the initial monitoring plan.

If the transaction changes materially after approval, it may need to return to the committee. Examples include a higher valuation, reduced investor protections, new liabilities or a significant deterioration in trading performance.

Investment committee oversight after closing

The original committee materials can remain relevant after investment. They provide a record of the assumptions, milestones and risks that supported the approval.

Ongoing review may compare actual performance with:

• the approved investment thesis;
• the base-case financial model;
• operational milestones;
• liquidity and working-capital assumptions;
• governance and reporting requirements;
• risk mitigation measures;
• expected future funding needs.

Significant deviations may require additional portfolio decisions, including follow-on funding, restructuring, changes in governance or a revised exit strategy.

How businesses can prepare for investment committee review

Businesses seeking private capital can improve the quality of the process by preparing information that can withstand independent challenge.

A committee-ready opportunity should normally include:

• a clear and evidence-based investment proposition;
• reliable historical financial information;
• a forecast connected to operational assumptions;
• a practical and specific use-of-funds plan;
• complete ownership and corporate records;
• material contracts and customer evidence;
• transparent disclosure of principal risks;
• realistic valuation expectations;
• willingness to discuss governance and reporting requirements.

Businesses considering a funding submission should review the Project Investment Terms before using the Sharemont Enquiry Desk.

Frequently asked questions

Does the investment committee meet the company’s management team?

Sometimes. The deal team may arrange management presentations or specialist sessions when direct discussion would help clarify strategy, operations or leadership capability. The exact format depends on the investor and transaction.

Can an investment be approved before due diligence is complete?

A committee may provide preliminary or conditional approval, but material diligence normally needs to be completed before capital is committed. Unresolved matters should be documented as conditions rather than treated as immaterial.

Does committee approval guarantee that the transaction will close?

No. Approval may remain subject to legal documentation, verification, third-party consents, financing conditions or other closing requirements. A material change can also cause the transaction to return to the committee.

Why might committee members disagree?

Members may interpret the evidence, valuation, downside exposure or portfolio impact differently. Structured disagreement can strengthen the process when the competing views are documented and addressed.

Can a declined opportunity be presented again?

Potentially. A transaction may be reconsidered when the business, evidence, valuation, structure or market conditions change materially. Reconsideration is not automatic and depends on the investor’s mandate and procedures.

Do all private investors use the same committee process?

No. A family office, institutional fund and private investment company may have different approval authorities and documentation standards. The general objective remains similar: to make an informed and accountable capital decision.

Final perspective

The investment committee process is designed to convert research, due diligence and professional judgment into an accountable capital decision. Its value lies not in creating certainty, but in ensuring that material assumptions and risks are considered before capital is committed.

A disciplined committee process tests mandate fit, evidence quality, valuation, downside exposure, portfolio impact and transaction structure. It also creates a formal record of the reasons for approval and the conditions that must be monitored after closing.

Prospective investors should review the Fund Investment Terms and the Risk Disclosure. General questions about Sharemont’s process can be submitted through the Contact Us page.